Meeting highlights from the Committee for Medicinal Products for Human ...
WEB4 days ago · EMA’s human medicines committee elects new Chair. The Committee for Human Medicinal Products (CHMP) elected Bruno Sepodes as its new chair. Professor Sepodes starts his three-year mandate on 21 September and succeeds Dr Harald Enzmann as chair, who completed the maximum two three-year terms allowed for CHMP chairs.
Meeting highlights from the Committee for Medicinal Products for Human ...
WEBJul 25, 2024 · EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its July 2024 meeting. The CHMP recommended granting a marketing authorisation for Anzupgo (delgocitinib), a medicine intended for the treatment of moderate to severe chronic hand eczema in adults for whom …
Meeting highlights from the Committee for Medicinal Products for Human ...
WEBJun 27, 2024 · EMA’s human medicines committee (CHMP) recommended ten medicines for approval at its June 2024 meeting. The committee recommended granting a marketing authorisation for Balversa (erdafitinib), for the treatment of adult patients with unresectable or metastatic urothelial carcinoma, a cancer of the bladder and urinary system.
Dupixent® (dupilumab) Recommended for EU Approval by the …
WEB3 days ago · --Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the European Medicines Agency’ s Committee for Medicinal Products for Human Use adopted a positive opinion recommending the ...
Pfizer Receives Positive CHMP Opinion for Conversion of …
WEBNew York, NY, January 27, 2023 – Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended converting the conditional Marketing Authorization (cMA) for PAXLOVID TM (nirmatrelvir tablets and ritonavir …
Meeting highlights from the Committee for Medicinal Products for Human ...
WEBMay 31, 2024 · EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its May 2024 meeting.
AbbVie Receives Positive CHMP Opinion for Mirvetuximab …
WEB3 days ago · NORTH CHICAGO, Ill., Sept. 20, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted ...
Novo Nordisk A/S: Wegovy® recommended by the European
WEB4 days ago · Bagsværd, Denmark, 19 September 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive ...
AbbVie Receives Positive CHMP Opinion for Mirvetuximab
WEB3 days ago · NORTH CHICAGO, Ill., Sept. 20, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted ...
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for ...
WEB3 days ago · In this article: INCHEON, South Korea and CAMBRIDGE, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the European Medicines ...